Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02974647
Title Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

mature T-cell and NK-cell lymphoma

primary cutaneous T-cell non-Hodgkin lymphoma

Therapies

Ruxolitinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.